Loading…
Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring
The clinical characteristics and prognosis remain unclear for nasal-type NK/T-cell lymphoma of Waldeyer ring (WR-NKTL). The aim of this study is to determine the clinical features and outcome. Ninety-one patients with WR-NKTL were reviewed. According to the Ann Arbor system, 15, 56, 12, and 8 patien...
Saved in:
Published in: | Blood 2008-10, Vol.112 (8), p.3057-3064 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c390t-76c96d332ae0d541d2b9b216ad089883ad533f13889ccede748291437fa1c0843 |
---|---|
cites | cdi_FETCH-LOGICAL-c390t-76c96d332ae0d541d2b9b216ad089883ad533f13889ccede748291437fa1c0843 |
container_end_page | 3064 |
container_issue | 8 |
container_start_page | 3057 |
container_title | Blood |
container_volume | 112 |
creator | Li, Ye-Xiong Fang, Hui Liu, Qing-Feng Lu, Jiade Qi, Shu-Nan Wang, Hua Jin, Jing Wang, Wei-Hu Liu, Yue-Ping Song, Yong-Wen Wang, Shu-Lian Liu, Xin-Fan Feng, Xiao-Li Yu, Zi-Hao |
description | The clinical characteristics and prognosis remain unclear for nasal-type NK/T-cell lymphoma of Waldeyer ring (WR-NKTL). The aim of this study is to determine the clinical features and outcome. Ninety-one patients with WR-NKTL were reviewed. According to the Ann Arbor system, 15, 56, 12, and 8 patients had stage I, II, III, and IV. Of patients with stage I and II, 54 received combined chemotherapy and radiotherapy (CMT), 13 received radiotherapy alone, and 4 patients received chemotherapy alone. All 20 patients with stage III/IV received primary chemotherapy. The disease is characterized by predominance in young males, good performance, a propensity for nodal involvement, frequent stage II through IV diseases, low frequency of elevated LDH, low-risk international prognostic index (IPI), high sensitivity to radiotherapy, and intermediate sensitivity to chemotherapy. The 5-year overall survival and progression-free survival for all patients were 65% and 51%, respectively. The age, B symptoms, stage, and IPI were important prognostic factors. CMT tended to improve the survival compared with radiotherapy alone for patients with stage I and II diseases. Both nodal involvement and distant extranodal dissemination were the primary failure patterns. WR-NKTL appears to have distinct clinical characteristics and favorable outcomes. |
doi_str_mv | 10.1182/blood-2008-05-160176 |
format | article |
fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2008_05_160176</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497120597097</els_id><sourcerecordid>S0006497120597097</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-76c96d332ae0d541d2b9b216ad089883ad533f13889ccede748291437fa1c0843</originalsourceid><addsrcrecordid>eNp9kE1rGzEQhkVJadyk_yAEXXJUM5J2V9KlUEy-aGgvKaEnIUuziYJ210jrgv995Ni0t5yGGZ53mHkIOePwlXMtLldpmgITAJpBy3gHXHUfyIK3og5AwBFZAEDHGqP4MflcygsAb6RoP5FjrjvVaWUW5M8yxTF6l2iPbt5kLNSNgc65dgOOM502s58GpFNPR1dcYvN2jfTnj8sH5jElmrbD-nka3A54dCngFjPNcXw6JR97lwp-OdQT8vv66mF5y-5_3dwtv98zLw3MTHXedEFK4RBC2_AgVmYleOcCaKO1dKGVsudSa-M9BlSNFqb-oXrHPehGnpBmv9fnqZSMvV3nOLi8tRzszpR9M2V3piy0dm-qxs73sfVmNWD4HzqoqcDFAXCl-umzG30s_zgBynAloXLf9hzWJ_9GzLb4iGO9NWb0sw1TfP-SV9Gyhvo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring</title><source>ScienceDirect - Connect here FIRST to enable access</source><creator>Li, Ye-Xiong ; Fang, Hui ; Liu, Qing-Feng ; Lu, Jiade ; Qi, Shu-Nan ; Wang, Hua ; Jin, Jing ; Wang, Wei-Hu ; Liu, Yue-Ping ; Song, Yong-Wen ; Wang, Shu-Lian ; Liu, Xin-Fan ; Feng, Xiao-Li ; Yu, Zi-Hao</creator><creatorcontrib>Li, Ye-Xiong ; Fang, Hui ; Liu, Qing-Feng ; Lu, Jiade ; Qi, Shu-Nan ; Wang, Hua ; Jin, Jing ; Wang, Wei-Hu ; Liu, Yue-Ping ; Song, Yong-Wen ; Wang, Shu-Lian ; Liu, Xin-Fan ; Feng, Xiao-Li ; Yu, Zi-Hao</creatorcontrib><description>The clinical characteristics and prognosis remain unclear for nasal-type NK/T-cell lymphoma of Waldeyer ring (WR-NKTL). The aim of this study is to determine the clinical features and outcome. Ninety-one patients with WR-NKTL were reviewed. According to the Ann Arbor system, 15, 56, 12, and 8 patients had stage I, II, III, and IV. Of patients with stage I and II, 54 received combined chemotherapy and radiotherapy (CMT), 13 received radiotherapy alone, and 4 patients received chemotherapy alone. All 20 patients with stage III/IV received primary chemotherapy. The disease is characterized by predominance in young males, good performance, a propensity for nodal involvement, frequent stage II through IV diseases, low frequency of elevated LDH, low-risk international prognostic index (IPI), high sensitivity to radiotherapy, and intermediate sensitivity to chemotherapy. The 5-year overall survival and progression-free survival for all patients were 65% and 51%, respectively. The age, B symptoms, stage, and IPI were important prognostic factors. CMT tended to improve the survival compared with radiotherapy alone for patients with stage I and II diseases. Both nodal involvement and distant extranodal dissemination were the primary failure patterns. WR-NKTL appears to have distinct clinical characteristics and favorable outcomes.</description><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2008-05-160176</identifier><identifier>PMID: 18676879</identifier><language>eng</language><publisher>Washington, DC: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents - therapeutic use ; Biological and medical sciences ; Child ; Combined Modality Therapy ; Disease-Free Survival ; Female ; Hematologic and hematopoietic diseases ; Humans ; Killer Cells, Natural - cytology ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Lymphoma, T-Cell - diagnosis ; Lymphoma, T-Cell - drug therapy ; Lymphoma, T-Cell - radiotherapy ; Male ; Medical sciences ; Middle Aged ; Nose Neoplasms - diagnosis ; Nose Neoplasms - drug therapy ; Nose Neoplasms - radiotherapy ; Prognosis ; Treatment Outcome</subject><ispartof>Blood, 2008-10, Vol.112 (8), p.3057-3064</ispartof><rights>2008 American Society of Hematology</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-76c96d332ae0d541d2b9b216ad089883ad533f13889ccede748291437fa1c0843</citedby><cites>FETCH-LOGICAL-c390t-76c96d332ae0d541d2b9b216ad089883ad533f13889ccede748291437fa1c0843</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0006497120597097$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3536,27901,27902,45756</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20791730$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18676879$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Ye-Xiong</creatorcontrib><creatorcontrib>Fang, Hui</creatorcontrib><creatorcontrib>Liu, Qing-Feng</creatorcontrib><creatorcontrib>Lu, Jiade</creatorcontrib><creatorcontrib>Qi, Shu-Nan</creatorcontrib><creatorcontrib>Wang, Hua</creatorcontrib><creatorcontrib>Jin, Jing</creatorcontrib><creatorcontrib>Wang, Wei-Hu</creatorcontrib><creatorcontrib>Liu, Yue-Ping</creatorcontrib><creatorcontrib>Song, Yong-Wen</creatorcontrib><creatorcontrib>Wang, Shu-Lian</creatorcontrib><creatorcontrib>Liu, Xin-Fan</creatorcontrib><creatorcontrib>Feng, Xiao-Li</creatorcontrib><creatorcontrib>Yu, Zi-Hao</creatorcontrib><title>Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring</title><title>Blood</title><addtitle>Blood</addtitle><description>The clinical characteristics and prognosis remain unclear for nasal-type NK/T-cell lymphoma of Waldeyer ring (WR-NKTL). The aim of this study is to determine the clinical features and outcome. Ninety-one patients with WR-NKTL were reviewed. According to the Ann Arbor system, 15, 56, 12, and 8 patients had stage I, II, III, and IV. Of patients with stage I and II, 54 received combined chemotherapy and radiotherapy (CMT), 13 received radiotherapy alone, and 4 patients received chemotherapy alone. All 20 patients with stage III/IV received primary chemotherapy. The disease is characterized by predominance in young males, good performance, a propensity for nodal involvement, frequent stage II through IV diseases, low frequency of elevated LDH, low-risk international prognostic index (IPI), high sensitivity to radiotherapy, and intermediate sensitivity to chemotherapy. The 5-year overall survival and progression-free survival for all patients were 65% and 51%, respectively. The age, B symptoms, stage, and IPI were important prognostic factors. CMT tended to improve the survival compared with radiotherapy alone for patients with stage I and II diseases. Both nodal involvement and distant extranodal dissemination were the primary failure patterns. WR-NKTL appears to have distinct clinical characteristics and favorable outcomes.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Combined Modality Therapy</subject><subject>Disease-Free Survival</subject><subject>Female</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Killer Cells, Natural - cytology</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Lymphoma, T-Cell - diagnosis</subject><subject>Lymphoma, T-Cell - drug therapy</subject><subject>Lymphoma, T-Cell - radiotherapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nose Neoplasms - diagnosis</subject><subject>Nose Neoplasms - drug therapy</subject><subject>Nose Neoplasms - radiotherapy</subject><subject>Prognosis</subject><subject>Treatment Outcome</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp9kE1rGzEQhkVJadyk_yAEXXJUM5J2V9KlUEy-aGgvKaEnIUuziYJ210jrgv995Ni0t5yGGZ53mHkIOePwlXMtLldpmgITAJpBy3gHXHUfyIK3og5AwBFZAEDHGqP4MflcygsAb6RoP5FjrjvVaWUW5M8yxTF6l2iPbt5kLNSNgc65dgOOM502s58GpFNPR1dcYvN2jfTnj8sH5jElmrbD-nka3A54dCngFjPNcXw6JR97lwp-OdQT8vv66mF5y-5_3dwtv98zLw3MTHXedEFK4RBC2_AgVmYleOcCaKO1dKGVsudSa-M9BlSNFqb-oXrHPehGnpBmv9fnqZSMvV3nOLi8tRzszpR9M2V3piy0dm-qxs73sfVmNWD4HzqoqcDFAXCl-umzG30s_zgBynAloXLf9hzWJ_9GzLb4iGO9NWb0sw1TfP-SV9Gyhvo</recordid><startdate>20081015</startdate><enddate>20081015</enddate><creator>Li, Ye-Xiong</creator><creator>Fang, Hui</creator><creator>Liu, Qing-Feng</creator><creator>Lu, Jiade</creator><creator>Qi, Shu-Nan</creator><creator>Wang, Hua</creator><creator>Jin, Jing</creator><creator>Wang, Wei-Hu</creator><creator>Liu, Yue-Ping</creator><creator>Song, Yong-Wen</creator><creator>Wang, Shu-Lian</creator><creator>Liu, Xin-Fan</creator><creator>Feng, Xiao-Li</creator><creator>Yu, Zi-Hao</creator><general>Elsevier Inc</general><general>Americain Society of Hematology</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20081015</creationdate><title>Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring</title><author>Li, Ye-Xiong ; Fang, Hui ; Liu, Qing-Feng ; Lu, Jiade ; Qi, Shu-Nan ; Wang, Hua ; Jin, Jing ; Wang, Wei-Hu ; Liu, Yue-Ping ; Song, Yong-Wen ; Wang, Shu-Lian ; Liu, Xin-Fan ; Feng, Xiao-Li ; Yu, Zi-Hao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-76c96d332ae0d541d2b9b216ad089883ad533f13889ccede748291437fa1c0843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Combined Modality Therapy</topic><topic>Disease-Free Survival</topic><topic>Female</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Killer Cells, Natural - cytology</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Lymphoma, T-Cell - diagnosis</topic><topic>Lymphoma, T-Cell - drug therapy</topic><topic>Lymphoma, T-Cell - radiotherapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nose Neoplasms - diagnosis</topic><topic>Nose Neoplasms - drug therapy</topic><topic>Nose Neoplasms - radiotherapy</topic><topic>Prognosis</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Ye-Xiong</creatorcontrib><creatorcontrib>Fang, Hui</creatorcontrib><creatorcontrib>Liu, Qing-Feng</creatorcontrib><creatorcontrib>Lu, Jiade</creatorcontrib><creatorcontrib>Qi, Shu-Nan</creatorcontrib><creatorcontrib>Wang, Hua</creatorcontrib><creatorcontrib>Jin, Jing</creatorcontrib><creatorcontrib>Wang, Wei-Hu</creatorcontrib><creatorcontrib>Liu, Yue-Ping</creatorcontrib><creatorcontrib>Song, Yong-Wen</creatorcontrib><creatorcontrib>Wang, Shu-Lian</creatorcontrib><creatorcontrib>Liu, Xin-Fan</creatorcontrib><creatorcontrib>Feng, Xiao-Li</creatorcontrib><creatorcontrib>Yu, Zi-Hao</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Ye-Xiong</au><au>Fang, Hui</au><au>Liu, Qing-Feng</au><au>Lu, Jiade</au><au>Qi, Shu-Nan</au><au>Wang, Hua</au><au>Jin, Jing</au><au>Wang, Wei-Hu</au><au>Liu, Yue-Ping</au><au>Song, Yong-Wen</au><au>Wang, Shu-Lian</au><au>Liu, Xin-Fan</au><au>Feng, Xiao-Li</au><au>Yu, Zi-Hao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring</atitle><jtitle>Blood</jtitle><addtitle>Blood</addtitle><date>2008-10-15</date><risdate>2008</risdate><volume>112</volume><issue>8</issue><spage>3057</spage><epage>3064</epage><pages>3057-3064</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><abstract>The clinical characteristics and prognosis remain unclear for nasal-type NK/T-cell lymphoma of Waldeyer ring (WR-NKTL). The aim of this study is to determine the clinical features and outcome. Ninety-one patients with WR-NKTL were reviewed. According to the Ann Arbor system, 15, 56, 12, and 8 patients had stage I, II, III, and IV. Of patients with stage I and II, 54 received combined chemotherapy and radiotherapy (CMT), 13 received radiotherapy alone, and 4 patients received chemotherapy alone. All 20 patients with stage III/IV received primary chemotherapy. The disease is characterized by predominance in young males, good performance, a propensity for nodal involvement, frequent stage II through IV diseases, low frequency of elevated LDH, low-risk international prognostic index (IPI), high sensitivity to radiotherapy, and intermediate sensitivity to chemotherapy. The 5-year overall survival and progression-free survival for all patients were 65% and 51%, respectively. The age, B symptoms, stage, and IPI were important prognostic factors. CMT tended to improve the survival compared with radiotherapy alone for patients with stage I and II diseases. Both nodal involvement and distant extranodal dissemination were the primary failure patterns. WR-NKTL appears to have distinct clinical characteristics and favorable outcomes.</abstract><cop>Washington, DC</cop><pub>Elsevier Inc</pub><pmid>18676879</pmid><doi>10.1182/blood-2008-05-160176</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-4971 |
ispartof | Blood, 2008-10, Vol.112 (8), p.3057-3064 |
issn | 0006-4971 1528-0020 |
language | eng |
recordid | cdi_crossref_primary_10_1182_blood_2008_05_160176 |
source | ScienceDirect - Connect here FIRST to enable access |
subjects | Adolescent Adult Aged Aged, 80 and over Antineoplastic Agents - therapeutic use Biological and medical sciences Child Combined Modality Therapy Disease-Free Survival Female Hematologic and hematopoietic diseases Humans Killer Cells, Natural - cytology Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Lymphoma, T-Cell - diagnosis Lymphoma, T-Cell - drug therapy Lymphoma, T-Cell - radiotherapy Male Medical sciences Middle Aged Nose Neoplasms - diagnosis Nose Neoplasms - drug therapy Nose Neoplasms - radiotherapy Prognosis Treatment Outcome |
title | Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T12%3A48%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20features%20and%20treatment%20outcome%20of%20nasal-type%20NK/T-cell%20lymphoma%20of%20Waldeyer%20ring&rft.jtitle=Blood&rft.au=Li,%20Ye-Xiong&rft.date=2008-10-15&rft.volume=112&rft.issue=8&rft.spage=3057&rft.epage=3064&rft.pages=3057-3064&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2008-05-160176&rft_dat=%3Celsevier_cross%3ES0006497120597097%3C/elsevier_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c390t-76c96d332ae0d541d2b9b216ad089883ad533f13889ccede748291437fa1c0843%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/18676879&rfr_iscdi=true |